IBI112 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
97潰瘍性大腸炎1

97. 潰瘍性大腸炎


臨床試験数 : 2,630 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05377580
(ClinicalTrials.gov)
July 1, 20226/5/2022A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative ColitisA Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of IBI112 in Patients With Moderate to Severe Active Ulcerative ColitisUlcerative Colitis (UC)Drug: Placebo;Drug: IBI112Innovent Biologics (Suzhou) Co. Ltd.NULLRecruiting18 Years75 YearsAll150Phase 2China